19 June 2013
Keywords: emea, updates, label, novartis, zometa, says, received
Article | 23 June 2003
Novartis says that it has received approval from the European Medicines Evaluation Agency to expand the current marketing
authorization for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 June 2003
30 June 2003
16 June 2003
© 2013 thepharmaletter.com